Abstract
The prognostic role of CD68 and FoxP3 in primary central nervous system lymphoma (PCNSL) has not been evaluated. Thus, we examined the prognostic significance of CD68 and FoxP3 expression in tumor samples of 76 newly diagnosed immunocompetent PCNSL patients. All patients were treated initially with high-dose methotrexate (HD-MTX)-based chemotherapy, and 16 (21.1%) patients received upfront autologous stem cell transplantation (ASCT) consolidation. High expression of CD68 (>55 cells/high-power field) or FoxP3 (>15 cells/high-power field) was observed in 10 patients, respectively. High CD68 expression was associated with inferior overall survival (OS) and progression-free survival (PFS) in multivariate analysis (P = 0.023 and P = 0.021, respectively). In addition, we performed subgroup analysis based on upfront ASCT. High CD68 expression was also associated with inferior OS and PFS in multivariate analysis (P = 0.013 and P < 0.001, respectively) among patients who did not receive upfront ASCT (n = 60), but not in patients who received upfront ASCT. The expression of FoxP3 was not significantly associated with survival. Therefore, we identified a prognostic significance of high CD68 expression in PCNSL, which suggests a need for f...Continue Reading
References
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrés J M FerreriFranco Cavalli
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lauren E AbreyUNKNOWN International Primary CNS Lymphoma Collaborative Group
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lauren E AbreyLisa M DeAngelis
Jun 9, 2007·British Journal of Haematology·M PonzoniUNKNOWN International Extranodal Lymphoma Study Group
Jan 11, 2008·Blood·Han W TunMichael McKinney
Feb 29, 2008·Blood·Sajjan MittalMark A Vickers
May 2, 2008·Cancer Letters·Antonio SicaAlberto Mantovani
May 23, 2008·Blood·Veronique Minard-ColinThomas F Tedder
Aug 19, 2008·Pathology International·Sverker HasselblomPer-Ola Andersson
Mar 12, 2010·The New England Journal of Medicine·Christian SteidlRandy D Gascoyne
Sep 28, 2010·International Journal of Cancer. Journal International Du Cancer·Daniel VenetzMariagrazia Uguccioni
Aug 6, 2011·Leukemia·M DeckertL M DeAngelis
Nov 23, 2011·Journal of Clinical and Experimental Hematopathology : JCEH·Yoshihiro KomoharaMotohiro Takeya
Mar 19, 2013·Neuro-oncology·Gareth GregoryStephen Opat
May 15, 2013·Nature Reviews. Neurology·Agnieszka Korfel, Uwe Schlegel
Jul 6, 2013·Neuro-oncology·Christine Lu-EmersonRakesh K Jain
Dec 24, 2013·Clinical Neuropathology·Anna Sophie BerghoffMatthias Preusser
Nov 9, 2014·Haematologica·Sari RiihijärviSirpa Leppa
Jan 9, 2015·Blood·Antonio OmuroCraig S Sauter
Jan 27, 2015·Neuro-oncology·Alissa A ThomasCamilo E Fadul
Feb 3, 2016·Blood·Andrés J M Ferreri, Gerald Illerhaus
Mar 29, 2016·British Journal of Haematology·Hyunsoo ChoJin Seok Kim
Aug 29, 2016·Journal of Experimental & Clinical Cancer Research : CR·Iole CordoneCarmine M Carapella
Citations
Sep 19, 2017·Current Opinion in Neurology·Louis Royer-PerronAgusti Alentorn
Nov 21, 2017·Oncotarget·Hyunsoo ChoJin Seok Kim
May 19, 2020·Journal of Cellular Physiology·Hua YangHua You
Mar 27, 2018·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Masaki KohSatoshi Kuroda
Jun 21, 2020·Cancers·Thomas RoetzerAdelheid Woehrer
Oct 17, 2019·PeerJ·Rui ChenQi Zhou
Apr 27, 2020·Cancer Immunology, Immunotherapy : CII·Lukas MarcelisThomas Tousseyn
Dec 5, 2021·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Mayur ParkhiBishan Dass Radotra